Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer Therapy
Tamoxifen breast cancer therapy provokes distinct gene expression patterns in endometrial tissues
February 23rd, 2006
Tamoxifen provokes distinct gene expression patterns in endometrial tissues. "Tamoxifen treatment for breast cancer increases proliferation of the endometrium, resulting in an enhanced prevalence of endometrial pathologies, including endometrial cancer. An exploratory study was performed to begin to understand the molecular mechanism of tamoxifen action in the endometrium," scientists writing in the journal Endocrine-Related Cancer report. "Gene-expression profiles were generated of endometrial samples of tamoxifen users and compared with matched controls. The pathological classification of samples from both groups included atrophic/inactive...
Source: Women's Health Weekly (2006-02-23)
|
